Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003297620 | SCV004009338 | uncertain significance | Cardiovascular phenotype | 2023-05-10 | criteria provided, single submitter | clinical testing | The p.F2460L variant (also known as c.7378T>C), located in coding exon 49 of the RYR2 gene, results from a T to C substitution at nucleotide position 7378. The phenylalanine at codon 2460 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003481484 | SCV004224831 | uncertain significance | not provided | 2022-04-28 | criteria provided, single submitter | clinical testing | PP3, PM2 |